Briggs Morrison

Track

Insider profile

Currently holds positions in Syndax Pharmaceuticals, Inc., Arvinas, Inc. and NextCure Inc

Performance

Overall performance
3.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
15 47% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 197%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Executive Officer, Director Syndax Pharmaceuticals, Inc. July 1, 2015 -
Independent Director Arvinas, Inc. June 1, 2018 -
Independent Director NextCure Inc April 1, 2019 -
Executive Vice President - Global Medicines Development AstraZeneca PLC Jan. 1, 2013 - Sept. 15, 2015
Briggs Morrison's trades of Arvinas, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Arvinas, Inc. (ARVN)
Transaction date
Purchase
Price
88.01
Quantity 89,657 -20.0%
Value US$2,395,449
US Arvinas, Inc. (ARVN)
Transaction date
Purchase
Price
188.71
Quantity 67,745 +4.6%
Value US$250,459
Transaction date
Proposed sale
Price
20.30
Quantity 52,855
Value US$1,072,956
US Arvinas, Inc. (ARVN)
Transaction date
Planned sale
Price
67.03
Quantity 10,754 -35.0%
Value US$720,888
US Arvinas, Inc. (ARVN)
Transaction date
Planned sale
Price
66.07
Quantity 7,104 -18.8%
Value US$469,356
US Arvinas, Inc. (ARVN)
Transaction date
Planned sale
Price
65.24
Quantity 3,102 -7.6%
Value US$202,372
US Arvinas, Inc. (ARVN)
Transaction date
Planned sale
Price
67.69
Quantity 2,108 -7.8%
Value US$142,696
US Arvinas, Inc. (ARVN)
Transaction date
Planned sale
Price
67.28
Quantity 5,100 -16.0%
Value US$343,144
US Arvinas, Inc. (ARVN)
Transaction date
Planned sale
Price
65.24
Quantity 3,833 -10.7%
Value US$250,071
US Arvinas, Inc. (ARVN)
Transaction date
Planned sale
Price
64.33
Quantity 9,919 -21.7%
Value US$638,109
Transaction date
Purchase
Price
21.00
Quantity 4,761 +inf%
Value US$99,981
Transaction date
Purchase
Price
20.00
Quantity 4,800 +inf%
Value US$96,000
US Arvinas, Inc. (ARVN)
Transaction date
Purchase
Price
38.18
Quantity 2,500 +9.3%
Value US$95,450
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-09 2026-03-06
US Arvinas, Inc. (ARVN)
B Purchase
89,657 -20.0%
88.01
US$2,395,449 		89,657 -20.0% 88.01 US$2,395,449
2025-09-24 2025-09-22
US Arvinas, Inc. (ARVN)
B Purchase
67,745 +4.6%
188.71
US$250,459 		67,745 +4.6% 188.71 US$250,459
2023-08-10 2023-08-09
S Sale
30,186 +22.6%
313.42
US$4,183,508 		30,186 +22.6% 313.42 US$4,183,508
2023-08-09 2023-08-09
PrS Proposed sale
52,855
18.25
US$964,604 		52,855 18.25 US$964,604
2023-07-11 2023-07-10
S Sale
52,855 -74.8%
20.40
US$1,078,068 		52,855 -74.8% 20.40 US$1,078,068
2023-07-10 2023-07-10
PrS Proposed sale
52,855
20.30
US$1,072,956 		52,855 20.30 US$1,072,956
2023-06-09 2023-06-09
PrS Proposed sale
52,855
21.32
US$1,126,869 		52,855 21.32 US$1,126,869
2023-06-09 2023-06-09
S Sale
28,273 -61.3%
21.18
US$598,797 		28,273 -61.3% 21.18 US$598,797
2023-06-09 2023-06-09
S Sale
24,582 -34.8%
21.18
US$520,625 		24,582 -34.8% 21.18 US$520,625
2023-05-10 2023-05-09
S Sale
52,855 -74.8%
21.41
US$1,131,478 		52,855 -74.8% 21.41 US$1,131,478
2023-05-09 2023-05-09
PrS Proposed sale
52,855
20.29
US$1,072,428 		52,855 20.29 US$1,072,428
2023-04-12 2023-04-10
S Sale
52,855 -74.8%
19.53
US$1,032,237 		52,855 -74.8% 19.53 US$1,032,237
2023-03-14 2023-03-13
PlS Planned sale
52,854 -74.8%
22.53
US$1,190,674 		52,854 -74.8% 22.53 US$1,190,674
2023-02-08 2023-02-06
PlS Planned sale
52,854 -74.8%
26.83
US$1,417,909 		52,854 -74.8% 26.83 US$1,417,909
2022-09-21 2022-09-20
PlS Planned sale
59,649 -77.0%
23.25
US$1,387,012 		59,649 -77.0% 23.25 US$1,387,012
2022-09-21 2022-09-19
PlS Planned sale
114,339 -86.5%
23.03
US$2,633,044 		114,339 -86.5% 23.03 US$2,633,044
2022-09-16 2022-09-16
PlS Planned sale
53,034 -74.8%
23.22
US$1,231,423 		53,034 -74.8% 23.22 US$1,231,423
2022-09-16 2022-09-16
PlS Planned sale
71,966 -80.1%
23.22
US$1,671,015 		71,966 -80.1% 23.22 US$1,671,015
2022-09-16 2022-09-15
PlS Planned sale
66,775 -78.9%
24.20
US$1,616,035 		66,775 -78.9% 24.20 US$1,616,035
2022-09-16 2022-09-14
PlS Planned sale
87,645 -83.1%
23.80
US$2,085,855 		87,645 -83.1% 23.80 US$2,085,855
2022-07-05 2022-07-01
PlS Planned sale
62,292 -77.7%
19.00
US$1,183,430 		62,292 -77.7% 19.00 US$1,183,430
2022-04-18 2022-04-14
US Arvinas, Inc. (ARVN)
PlS Planned sale
10,754 -35.0%
67.03
US$720,888 		10,754 -35.0% 67.03 US$720,888
2022-04-18 2022-04-14
US Arvinas, Inc. (ARVN)
PlS Planned sale
7,104 -18.8%
66.07
US$469,356 		7,104 -18.8% 66.07 US$469,356
2022-04-18 2022-04-14
US Arvinas, Inc. (ARVN)
PlS Planned sale
3,102 -7.6%
65.24
US$202,372 		3,102 -7.6% 65.24 US$202,372
2022-04-05 2022-04-04
PlS Planned sale
3,128 -14.9%
18.29
US$57,220 		3,128 -14.9% 18.29 US$57,220
2022-04-05 2022-04-01
PlS Planned sale
70,545 -79.8%
17.46
US$1,231,568 		70,545 -79.8% 17.46 US$1,231,568
2022-04-05 2022-04-01
PlS Planned sale
24,500 -57.9%
17.44
US$427,314 		24,500 -57.9% 17.44 US$427,314
2022-04-05 2022-04-01
PlS Planned sale
6,000 -12.4%
17.44
US$104,633 		6,000 -12.4% 17.44 US$104,633
2022-01-19 2022-01-14
US Arvinas, Inc. (ARVN)
PlS Planned sale
2,108 -7.8%
67.69
US$142,696 		2,108 -7.8% 67.69 US$142,696
2022-01-19 2022-01-14
US Arvinas, Inc. (ARVN)
PlS Planned sale
5,100 -16.0%
67.28
US$343,144 		5,100 -16.0% 67.28 US$343,144
2022-01-19 2022-01-14
US Arvinas, Inc. (ARVN)
PlS Planned sale
3,833 -10.7%
65.24
US$250,071 		3,833 -10.7% 65.24 US$250,071
2022-01-19 2022-01-14
US Arvinas, Inc. (ARVN)
PlS Planned sale
9,919 -21.7%
64.33
US$638,109 		9,919 -21.7% 64.33 US$638,109
2021-12-20 2021-12-17
PlS Planned sale
35,156 -42.1%
20.00
US$703,120 		35,156 -42.1% 20.00 US$703,120
2021-02-17 2021-02-17
B Purchase
4,761 +inf%
21.00
US$99,981 		4,761 +inf% 21.00 US$99,981
2021-02-10 2021-02-08
PlS Planned sale
35,156 -42.1%
20.55
US$722,403 		35,156 -42.1% 20.55 US$722,403
2020-11-12 2020-11-10
S Sale
17,466 -27.3%
20.06
US$350,312 		17,466 -27.3% 20.06 US$350,312
2020-11-12 2020-11-09
S Sale
62,938 -57.5%
20.04
US$1,261,265 		62,938 -57.5% 20.04 US$1,261,265
2020-06-25 2020-06-23
B Purchase
4,800 +inf%
20.00
US$96,000 		4,800 +inf% 20.00 US$96,000
2020-03-25 2020-03-24
US Arvinas, Inc. (ARVN)
B Purchase
2,500 +9.3%
38.18
US$95,450 		2,500 +9.3% 38.18 US$95,450
2020-02-05 2020-02-04
B Purchase
12,500 +39.8%
8.00
US$100,000 		12,500 +39.8% 8.00 US$100,000
2019-10-11 2019-10-10
B Purchase
11,000 +53.9%
5.40
US$59,400 		11,000 +53.9% 5.40 US$59,400
2019-05-13 2019-05-13
B Purchase
7,200 +54.5%
7.29
US$52,517 		7,200 +54.5% 7.29 US$52,517
2019-05-13 2019-05-09
B Purchase
13,200 +inf%
7.56
US$99,726 		13,200 +inf% 7.56 US$99,726